SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-05-049558
Filing Date
2005-03-14
Accepted
2005-03-14 16:51:39
Documents
1
Group Members
ALAN G. WALTONJEFFREY T. BARNESJONATHAN J. FLEMINGMARK P. CARTHYMICHAEL E. LYTTONOBP MANAGEMENT IV L.P.OXFORD BIOSCIENCE PARTNERS IV L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.htm SC 13D 175911
  Complete submission text file 0001193125-05-049558.txt   177545
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
Solexa, Inc. (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45671 | Film No.: 05678927
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address 31 ST JAMES AVENUE SUITE 905 BOSTON MA 02116 617-357-7474
MRNA FUND II LP (Filed by) CIK: 0001161302 (see all company filings)

IRS No.: 000000000
Type: SC 13D